← Leaderboards
Kate W Rittenhouse-Olson
For-Robin
$2,844,868
Attributed
$3,129,876
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2013–23$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,129,876 · 4
By mechanism
R42$1,986,991 · 1
R21$427,512 · 1
R41$411,055 · 1
R43$304,318 · 1
Others in their field
Top investigators on “Normal Tissue Morphology”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,450,141
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Walter John Curran · Thomas Jefferson University$26,641,549
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$24,664,682
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,339,595
- Larry Arthur$20,205,250
Research focus
Normal Tissue MorphologyCancer PatientTumorAntibodiesMalignant Breast NeoplasmSpecificityMonoclonal AntibodiesMalignant NeoplasmsCarcinomaDiagnosticNeoplasm MetastasisToxicologyRadiolabeledBiologicalIgg1Cancer CellCancer DiagnosisConventional TherapyComplementDiagnosisDrug KineticsChest Computed TomographyCellsClinical Application
Grant awards (7)
Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection$219,559
R21 · FY2023 · CA
Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection$207,953
R21 · FY2022 · CA
JAA-F11 Anti-Thomsen-Friedenreich Antigen Targeted Imaging for Lung Cancer Differential Diagnosis$304,318
R43 · FY2019 · CA · contact PI
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$1,013,625
R42 · FY2016 · CA · contact PI
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$973,366
R42 · FY2015 · CA · contact PI
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$128,831
R41 · FY2014 · CA · contact PI
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$282,224
R41 · FY2013 · CA · contact PI